914224-31-0 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-Amino-2-fluorophenyl) acetic acid is used as a key intermediate in the synthesis of pharmaceuticals for the treatment of various conditions. Its unique structure allows for the development of new drugs with potential therapeutic effects against cancer and inflammatory diseases.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(4-Amino-2-fluorophenyl) acetic acid is utilized as a building block for the creation of novel agrochemicals. Its properties contribute to the development of effective compounds for pest control and crop protection, enhancing agricultural productivity and sustainability.
It is important to handle 2-(4-Amino-2-fluorophenyl) acetic acid with care and follow safety protocols when working with it in a laboratory setting to ensure the safety of researchers and the integrity of the experiments.
Check Digit Verification of cas no
The CAS Registry Mumber 914224-31-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,4,2,2 and 4 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 914224-31:
(8*9)+(7*1)+(6*4)+(5*2)+(4*2)+(3*4)+(2*3)+(1*1)=140
140 % 10 = 0
So 914224-31-0 is a valid CAS Registry Number.
914224-31-0Relevant academic research and scientific papers
TRISUBSTITUTED HETEROCYCLIC DERIVATIVES AS ROR GAMMA MODULATORS
-
Page/Page column 35, (2014/09/03)
The present invention provides trisubstituted heterocyclic derivatives of formula (I), which may be therapeutically useful, more particularly as RORγ modulators; (I) in which R1, R2, R3, Ra, X, L, m and ring A have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorder, in particular their use in diseases or disorder where there is an advantage in modulating RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the trisubstituted heterocyclic derivatives of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient therefor.
NOVEL COMPOUNDS
-
Page/Page column 127, (2013/03/28)
Disclosed are novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.
